Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma.

Abstract:

:Euchromatic histone-lysine N-methyltransferase (G9A), the primary histone methyltransferase for histone H3 Lys9, has been identified to be upregulated in numerous types of cancer. The aim of the present study was to analyze the clinical significance of G9A, and preliminarily explore its function in hepatocellular carcinoma (HCC). An increased expression level of G9A was demonstrated in the HCC samples and also in 5 publically available datasets. By analyzing GSE14520, it was revealed that its expression level was significantly associated with serum α-fetoprotein level of patients with HCC, and may serve as a potential prognostic indicator for patients with multinodular HCC. Bioinformatics tools were utilized to predict the potential function of G9A, and the results indicated that G9A may modulate gene sets involved in RNA processing and DNA replication. G9A inhibition may suppress cell proliferation by arresting cells in G1 phase and increasing the expression level of microtubule-associated protein light chain 3β (MAP1LC3B) in Huh7 and HepG2 cells. In addition, an inverse association between the expression of G9A and LC3B was demonstrated in HCC tumor samples in the publically available GSE14520 dataset, which indicated that G9A may also have the potential to regulate MAP1LC3B expression in HCC tumor tissues. The results of the present study led to hypothesis that the G9A expression level may be of assistance in diagnosing HCC, and be a potential therapeutic target for HCC. The results provided novel evidence for additional understanding of the crucial role of G9A in tumorigenesis.

journal_name

Oncol Lett

journal_title

Oncology letters

authors

Qin J,Li Q,Zeng Z,Wu P,Jiang Y,Luo T,Ji X,Zhang Q,Hao Y,Chen L

doi

10.3892/ol.2018.8572

subject

Has Abstract

pub_date

2018-06-01 00:00:00

pages

9757-9765

issue

6

eissn

1792-1074

issn

1792-1082

pii

OL-0-0-8572

journal_volume

15

pub_type

杂志文章
  • Clinicopathological and mutational differences between tumors with multiple metastases and single lung metastasis in colorectal cancer.

    abstract::Cancer metastasis, particularly multiple metastatic cancer, is a significant event that affects patient prognosis. However, single metastasis can be treated by partial resection, although the clinicopathological and molecular profile of single lung metastasis has not been thoroughly elucidated. The present study exami...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.11627

    authors: Yanai Y,Hayashi T,Akazawa Y,Yatagai N,Tsuyama S,Yao T,Saito T

    更新日期:2020-07-01 00:00:00

  • miR-451a suppression of IL-6R can inhibit proliferation and increase apoptosis through the JAK2/STAT3 pathway in multiple myeloma.

    abstract::The IL-6R/JAK2/STAT3 pathway mediated by interleukin-6 (IL-6) plays an important role in the occurrence and development of multiple myeloma (MM), which is associated with decreased microRNA-451a. However, the biological function of microRNA-451a in MM remains unclear. The bone marrow (BM) of patients with MM was sampl...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.12202

    authors: Zhong L,Xu Z,Jin X,He Y,Zhang J,Jiang T,Chen J

    更新日期:2020-12-01 00:00:00

  • Expression of TARBP1 protein in human non-small-cell lung cancer and its prognostic significance.

    abstract::The aim of the present study was to investigate the expression of transactivation response RNA-binding protein (TARBP)1 and its clinical significance in human non-small-cell lung cancer (NSCLC). TARBP1 expression at the mRNA level was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) i...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8202

    authors: Ye J,Wang J,Zhang N,Liu Y,Tan L,Xu L

    更新日期:2018-05-01 00:00:00

  • Side population in hepatocellular carcinoma HCCLM3 cells is enriched with stem-like cancer cells.

    abstract::Substantial evidence implicates that low-abundance cancer stem cells (CSCs) are responsible for tumor metastasis and recurrence in hepatocellular carcinoma (HCC). Side population (SP) cells possess typical CSCs-like features, and are frequently considered as a special subpopulation in which CSCs are enriched and in st...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4343

    authors: Guo Z,Jiang JH,Zhang J,Yang HJ,Zhong YP,Su J,Yang RR,Li LQ,Xiang BD

    更新日期:2016-05-01 00:00:00

  • Inhibitory effect of MyoD on the proliferation of breast cancer cells.

    abstract::Skeletal muscle is rich in lymphatic vessels, with an abundant blood supply, and it is an infrequent site of cancer metastasis. Previous studies have demonstrated that enhanced secretion of MyoD may occur when skeletal muscle is injured or becomes cancerous. It was hypothesized that MyoD may act as an endogenous cytok...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4448

    authors: Cai C,Qin X,Wu Z,Shen Q,Yang W,Zhang S,Duan J,Liang F,Liu C

    更新日期:2016-06-01 00:00:00

  • Photodynamic therapy combined with cryotherapy for the treatment of nodular basal cell carcinoma.

    abstract::Carbon dioxide (CO2) laser ablation in combination with photodynamic therapy (PDT) has previously been successfully used to treat superficial basal cell carcinoma (BCC). However, the efficacy of this treatment modality is limited in the treatment of deeper lesions and the more aggressive subtypes of BCC. In order to i...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2013.1504

    authors: Kim SA,Lee KS,Cho JW

    更新日期:2013-10-01 00:00:00

  • Precursor B cell lymphoid blast crisis of chronic myeloid leukemia with novel chromosomal abnormalities: A case report.

    abstract::Chronic myeloid leukemia (CML) is a clonal hematopoietic stem cell disorder. It is characterized by the presence of the Philadelphia (Ph) chromosome, t(9;22)(q34.1;q11.2), which carries the BCR-ABL1 fusion gene. Tyrosine kinase inhibitors (TKIs) have markedly changed the treatment approach of CML and have become the f...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.9497

    authors: Al-Khallaf H,Alali H,Alkhatti A

    更新日期:2018-11-01 00:00:00

  • Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor.

    abstract::Janus kinase 2 (JAK2) is a non-receptor tyrosine kinase that regulates the signal transducer and activator of transcription (STAT) signaling pathway. Deregulation of JAK2 signaling has previously been observed in hematologic malignancies, including erythroleukemia. In the present study, an aminopyridine derivative com...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6353

    authors: Yoon KB,Cho SY,An SJ,Park KR,Lee HJ,Yoon HS,Lee SM,Kim YC,Han SY

    更新日期:2017-08-01 00:00:00

  • Low accuracy of chromogranin A for diagnosing early-stage pancreatic neuroendocrine tumors.

    abstract::The aim of the present study was to evaluate the clinical utility of plasma chromogranin A (CgA) in patients diagnosed with early-stage pancreatic neuroendocrine tumors (PNETs) in terms of diagnostic value and treatment response. A total of 35 patients with PNETs were prospectively enrolled from August 2010 to April 2...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8472

    authors: Tseng CM,Cheng TY,Chen TB,Tien YW,Chen CC,Lin JT,Wang HP

    更新日期:2018-06-01 00:00:00

  • Prioritization of non-coding disease-causing variants and long non-coding RNAs in liver cancer.

    abstract::There are multiple bioinformatics tools available for the detection of coding driver mutations in cancers. However, the prioritization of pathogenic non-coding variants remains a challenging and demanding task. The present study was performed to discriminate non-coding disease-causing mutations and prioritize potentia...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.5135

    authors: Li H,He Z,Gu Y,Fang L,Lv X

    更新日期:2016-11-01 00:00:00

  • MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review).

    abstract::MicroRNAs (miRNAs) are small non-coding RNAs of approximately 22 base pairs that regulate the expression of genes by targeting messenger RNA with complementarity with the miRNA base sequence. Regulation of gene expression by miRNAs is crucial in cellular development and differentiation, and recent studies suggest a re...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2010.173

    authors: Yanokura M,Banno K,Kobayashi Y,Kisu I,Ueki A,Ono A,Masuda K,Nomura H,Hirasawa A,Susumu N,Aoki D

    更新日期:2010-11-01 00:00:00

  • Single nucleotide polymorphisms in the HIF-1α gene and chemoradiotherapy of locally advanced rectal cancer.

    abstract::The aim of this study was to investigate the predictive impact of polymorphisms in the HIF-1α gene on the response to chemoradiotherapy (CRT) in rectal cancer. This study included two cohorts of patients with locally advanced rectal cancer receiving long-course CRT. The HIF-1α C1772T (rs11549465), G1790A (rs11549467) ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2012.837

    authors: Havelund BM,Spindler KL,Ploen J,Andersen RF,Jakobsen A

    更新日期:2012-11-01 00:00:00

  • miR-493 inhibits proliferation and invasion in pancreatic cancer cells and inversely regulated hERG1 expression.

    abstract::The human ether-a-go-go-related potassium channel 1 (hERG1) is a component of the voltage-gated Kv11.1 potassium channel, which has been recently indicated to have a crucial role in the tumorigenesis of multiple tumors, including pancreatic carcinoma. Pancreatic carcinoma is one of the most malignant human cancer type...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.7178

    authors: Zhi D,Zhao X,Dong M,Yan C

    更新日期:2017-12-01 00:00:00

  • Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens.

    abstract::The association between inflammation and cancer has been established in certain forms of human malignancies; however, its role in prostate cancer remains unclear. The present study investigates a possible association between chronic inflammation and the development of epithelial neoplasia in the prostate. Needle biops...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6668

    authors: Glover M,Soni S,Ren Q,Maclennan GT,Fu P,Gupta S

    更新日期:2017-10-01 00:00:00

  • The rare case of giant cell tumor occuring in the axial skeleton after 15 years of follow-up: Case report.

    abstract::The majority of giant cell tumors (GCTs) occur in the ends of the long bones. The presence of more than one GCT in the axial skeleton is rare. A GCT is capable of remaining clinically latent following treatment and becoming active a number of years later. We report an extremely rare case of GCT occurring in the axial ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2011.402

    authors: Park YS,Lee JK,Baek SW,Park CK

    更新日期:2011-11-01 00:00:00

  • Partial response of liver metastases treated with abiraterone in castration-resistant prostate cancer: A case report.

    abstract::Docetaxel is the current first-line treatment for castration-resistant prostate cancer (CRPC), following failure to respond to maximal androgen blockade (MAB). Patients who fail to respond to docetaxel may receive cabazitaxel or abiraterone; however, there are no recommendations on which of these two agents should be ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2013.1275

    authors: Marech I,Vacca A,Sivestris N,Gnoni A,Lorusso V

    更新日期:2013-06-01 00:00:00

  • Multicomponent nutritional supplement Oncoxin and its influence on quality of life and therapy toxicity in patients receiving adjuvant chemotherapy.

    abstract::Treatment of cancer often requires the use of adjuvant chemotherapy (ACT). In real clinical practice, numerous patients suffer from severe toxicity and reduced quality of life (QoL). Hence, there is a need to maintain QoL and to reduce therapy toxicity to comply with recommended chemotherapy (CT) regimens. The present...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10868

    authors: Kaidarova DR,Kopp MV,Pokrovsky VS,Dzhugashvili M,Akimzhanova ZM,Abdrakhmanov RZ,Babich EN,Bilan EV,Byakhov AV,Gurov SN,Koroleva IA,Mochalova AS,Povaga SS,Raigorodsky MV,Saifullin AS,Sanz E,Petrovskiy FI

    更新日期:2019-11-01 00:00:00

  • Pre-treatment neutrophil to lymphocyte ratio as a predictive marker for pathological response to preoperative chemoradiotherapy in pancreatic cancer.

    abstract::An elevated neutrophil to lymphocyte ratio (NLR) has been reported to be associated with the pathological response to neoadjuvant therapies in numerous types of cancer. The aim of the current study was to clarify the association between pre-treatment NLR and the pathological response to preoperative chemoradiotherapy ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.4057

    authors: Hasegawa S,Eguchi H,Tomokuni A,Tomimaru Y,Asaoka T,Wada H,Hama N,Kawamoto K,Kobayashi S,Marubashi S,Konnno M,Ishii H,Mori M,Doki Y,Nagano H

    更新日期:2016-02-01 00:00:00

  • Intranasal dexmedetomidine combined with local anesthesia for conscious sedation during breast lumpectomy: A prospective randomized trial.

    abstract::Breast lumpectomy is usually performed under general or local anesthesia. To the best of our knowledge, whether conscious sedation with intranasal dexmedetomidine and local anesthesia is an effective anesthetic technique has not been studied. Thus, the present study aimed to investigate the effectiveness of conscious ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.11938

    authors: Yuan YJ,Zhou P,Xia F,Zhang XB,He SS,Guo DY,Xing YH,Zhao HW

    更新日期:2020-10-01 00:00:00

  • CAR-T 19 combined with reduced-dose PD-1 blockade therapy for treatment of refractory follicular lymphoma: A case report.

    abstract::Anti-CD19 chimeric antigen receptor T cell (CAR-T) therapy has changed the typical outcomes of relapsed/refractory B-cell leukemia and lymphoma. However, treatment effectiveness for patients with relapsed/refractory B-cell non-Hodgkin lymphoma has been less satisfactory compared with patients with B-cell acute lymphob...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10783

    authors: Wang J,Deng Q,Jiang YY,Zhang R,Zhu HB,Meng JX,Li YM

    更新日期:2019-11-01 00:00:00

  • Synergy of Taxol and rhein lysinate associated with the downregulation of ERK activation in lung carcinoma cells.

    abstract::In previous studies we observed that rhein lysinate (RHL), a salt of rhein and lysine that is easily dissolved in water, inhibited the growth of tumor cells in breast cancer, ovarian cancer, hepatocellular carcinoma and cervical cancer. The present study aimed to investigate the effects of RHL on H460 and A549 non-sma...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2013.1398

    authors: Zhen YZ,Hu G,Zhao YF,Yan F,Li R,Gao JL,Lin YJ

    更新日期:2013-08-01 00:00:00

  • STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis.

    abstract::Ulcerative colitis (UC) is thought to be associated with precancerous lesions that can ultimately lead to colon cancer. Therefore, diagnostic markers for colorectal dysplasia and cancer are urgently needed for patients with UC. Stathmin 1 (STMN1) is a novel cancer biomarker that is also a novel target for treatment in...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10814

    authors: Osone K,Yokobori T,Katayama C,Takahashi R,Kato R,Tatsuski H,Takada T,Yajima R,Motegi Y,Ogawa H,Fujii T,Ojima H,Nakamura J,Yao T,Shirabe K,Kuwano H

    更新日期:2019-11-01 00:00:00

  • Long non-coding RNA NBAT1 inhibits the progression of glioma through the miR-21/SOX7 axis.

    abstract::Glioma is one of the most prevalent types of malignancy in the central nervous system worldwide, and the prognosis of patients with late stage glioma remains poor. Thus, the development of promising therapeutic strategies against glioma is essential. Long non-coding RNAs (lncRNAs) are functional RNA molecules involved...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.11847

    authors: Guan N,Wang R,Feng X,Li C,Guo W

    更新日期:2020-09-01 00:00:00

  • Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma.

    abstract::Urothelial carcinoma (UC) is the most common type of cancer of the bladder and upper urinary tract, and is characterized by a high risk of recurrence and progression. Urine fluorescence in situ hybridization (FISH) is a technique that detects genetic aberrations in exfoliated cells in the urine, with specific probes f...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.5926

    authors: Lin T,Liu Z,Liu L,Yang L,Han P,Zhang P,Wei Q

    更新日期:2017-05-01 00:00:00

  • Two postoperative chemotherapies for gastric cancer: FOLFOX4 vs. TPF.

    abstract::Clinical effects of FOLFOX4 and TPF chemotherapy regimen on postoperative gastric cancer patients were investigated. A total of 60 patients admitted to the First People's Hospital of Changzhou receiving gastric cancer operation were selected and they were divided into two groups at random. Thirty patients in the FOLFO...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.9695

    authors: Xie H,Lu Q,Wang H,Zhu X,Guan Z

    更新日期:2019-01-01 00:00:00

  • Dosimetric comparison between IMRT and VMAT in irradiation for peripheral and central lung cancer.

    abstract::The aim of the present study was to compare intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) in irradiation of lung cancer. Plans of 14 patients were compared. The results demonstrated that in peripheral lung cancer, V5 (%) of the lung in partial-arc (PA)-VMAT was decreased comp...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.7732

    authors: Li Y,Wang J,Tan L,Hui B,Ma X,Yan Y,Xue C,Shi X,Drokow EK,Ren J

    更新日期:2018-03-01 00:00:00

  • Malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and treated simultaneously: A case report.

    abstract::Malignant melanoma can be successfully treated when it is identified in its early stages, but the disease is associated with a poor prognosis when it is detected in an advanced stage. Papillary thyroid carcinoma is a thyroid cancer that has a good prognosis. The present study reports a rare case of malignant melanoma ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.2642

    authors: Ozgun A,Tuncel T,Emirzeoglu L,Celik S,Bilgi O,Haholu A,Urhan M,Karagoz B

    更新日期:2015-01-01 00:00:00

  • CD44 promotes cell proliferation in non-small cell lung cancer.

    abstract::Cluster of differentiation 44 (CD44), a marker for cancer stem cells, has been reported to be associated with poor prognosis in non-small cell lung cancer (NSCLC), but its involvement in tumor growth has not fully been elucidated. The present study explored the associations between CD44 expression and clinicopathologi...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8051

    authors: Hu B,Ma Y,Yang Y,Zhang L,Han H,Chen J

    更新日期:2018-04-01 00:00:00

  • FFJ-3 inhibits PKM2 protein expression via the PI3K/Akt signaling pathway and activates the mitochondrial apoptosis signaling pathway in human cancer cells.

    abstract::Pyruvate kinase isoenzyme M2 (PKM2) has previously been identified as a tumor biomarker and potential therapeutic target for the treatment of cancer. In the present study, FFJ-3, a structurally modified version of mollugin, an extract of the Traditional Chinese herbal medicine Rubia tinctorum (madder) was used in orde...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.5761

    authors: Li D,Wei X,Ma M,Jia H,Zhang Y,Kang W,Wang T,Shi X

    更新日期:2017-04-01 00:00:00

  • Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.

    abstract::Matrix metalloproteinases (MMPs) are enzymes for extracellular matrix remodeling that are involved in tumor growth, progression and metastasis. Among them, MMP-9 has been implicated in tumor angiogenesis. Tissue inhibitor of matrix metalloproteinase (TIMP)-2, a member of the family of MMP inhibitors, induces apoptosis...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2013.1767

    authors: Wajner SM,Capp C,Brasil BA,Meurer L,Maia AL

    更新日期:2014-03-01 00:00:00